Joint (NASDAQ:JYNT) Share Price Crosses Above Fifty Day Moving Average – Time to Sell?

The Joint Corp. (NASDAQ:JYNT)’s share price passed above its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of $11.24 and traded as high as $11.38. Joint shares last traded at $11.34, with a volume of 18,578 shares changing hands.

Joint Price Performance

The company has a market capitalization of $165.46 million, a PE ratio of -14.73 and a beta of 1.57. The stock has a 50-day simple moving average of $11.24 and a 200 day simple moving average of $12.99.

Joint (NASDAQ:JYNT) last announced its earnings results on Thursday, August 8th. The company reported ($0.06) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.05). The business had revenue of $30.26 million for the quarter, compared to analyst estimates of $29.65 million. Joint had a positive return on equity of 2.17% and a negative net margin of 12.00%. As a group, research analysts predict that The Joint Corp. will post 0.13 EPS for the current fiscal year.

Institutional Investors Weigh In On Joint

Large investors have recently bought and sold shares of the stock. Squarepoint Ops LLC acquired a new position in shares of Joint in the second quarter valued at approximately $144,000. Sargent Investment Group LLC purchased a new stake in Joint in the 2nd quarter worth approximately $150,000. XTX Topco Ltd purchased a new stake in shares of Joint in the second quarter valued at $174,000. Price T Rowe Associates Inc. MD boosted its stake in Joint by 5.0% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 17,464 shares of the company’s stock worth $229,000 after buying an additional 837 shares during the last quarter. Finally, Avondale Wealth Management grew its holdings in Joint by 15.8% in the 2nd quarter. Avondale Wealth Management now owns 22,000 shares of the company’s stock valued at $309,000 after buying an additional 3,000 shares during the period. Institutional investors and hedge funds own 76.88% of the company’s stock.

Joint Company Profile

The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.